Skip to main content
Equibles

NYMXF · Nymox Pharmaceutical Corp · Analyst Estimates

Track NYMXF — free

Use NYMXF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NYMXF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.03 +0.00 (+0.00%) At close · Oct 5
Rebalance outlook locked
Market Cap
$10.50M
Shares
105.04M
Volume · Oct 5 12.05K Avg daily vol (3M) 13.56K

Analyst Estimates

Compare analyst forecasts for Nymox Pharmaceutical Corp across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Published by the company

No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.

No published consensus found

No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.

Key facts CIK 1018735 CUSIP P73398102 13F (30d) 1 filings 1 filers Visit website Investor relations